UroLift — Prostatic Urethral Lift (PUL)
UroLift is a mechanical prostatic tissue-retraction implant system used for BPH-related bladder outlet obstruction. Small nitinol / stainless-steel implants are deployed transurethrally to retract the lateral prostatic lobes away from the urethral lumen, creating a wider channel without tissue resection or ablation.
Device & Mechanism
- Implant consists of a stainless-steel urethral capsular tab, a nitinol urethral tab, and a monofilament polyester suture connecting them through the prostatic parenchyma
- Deployed via a dedicated transurethral delivery handpiece under direct cystoscopic visualization
- Typically 2–4 implants per prostate; patient-dependent
Indications
- BPH-related LUTS with predominantly lateral-lobe obstruction
- Patients who:
- Wish to preserve ejaculation (PUL has high ejaculation-preservation rates)
- Want to avoid TURP / ablative BPH therapy
- Need to preserve sexual function
- Contraindications: median-lobe obstruction, prostate >80 g (relative), prior TURP
Reconstructive Relevance
The UroLift is primarily a BPH-management device, but reconstructive urologists encounter:
- Device complications — misplaced implants, urethral erosion of the urethral tab, persistent LUTS
- Device-adjacent reconstruction — stricture or contracture after UroLift in select patients
- Imaging findings — implants are clearly visible on CT and should not be mistaken for foreign body or calculus by readers unfamiliar with the device
See also: Himplant.